Unlq6073 PDF

Vijaya Diagnostic Centre
16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.

Helpline : 040-21000000
Email : info@vijayadiagnostic.com
www.vijayadiagnostic.com
LABORATORY TEST REPORT

Regn Date : 04/01/2020 10:30 Sample Collection : 04/01/2020 10:33
Name : MR. R RAVI Print Date : 05/01/2020 12:29
Regn No : 33200664 Age / Sex : 50 Years / Male
Ref By : SELF Regn Centre : Vanasthalipuram - 33
Sample Type : Serum Ref no. :
CREATININE
TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL
Creatinine : 0.8 Adult Male : 0.7 - 1.2 mg/dL

Neonate : 0.3 - 1.0 mg/dL
Infant : 0.2 - 0.4 mg/dL
Children : 0.3 - 0.8 mg/dL mg/dL
Method : Jaffe Kinetic IDMS traceable
Comments / Interpretation :
-------------------------------
- Useful in the diagnosis of renal insufficiency and is more specific and sensitive indicator of renal disease than of BUN.
- Use of simultaneous BUN and creatinine levels provide more information in the diagnosis of renal insufficiency.
DR.SYED SHABBAR MASIH

CONSULTANT BIOCHEMIST
Released Date 04/01/2020 15:53 Page 1 of 5

*33200664*
Helpline : 040-21000000

Sample Type : Fluoride Plasma Ref no. :
FASTING PLASMA GLUCOSE (FPG)

Fasting Plasma Glucose : 136 Normal : 70-100 mg/dL

Impaired Fasting Glucose : 101-125 mg/dL
Diabetes : >/=126 mg/dL
Method : Hexokinase
---------------------------------
- ADA Guidelines (2019) are adopted for the evaluation of Diabetic Status.
POST LUNCH PLASMA GLUCOSE (PLPG)
2 hrs Post Lunch Plasma Glucose : 170 Normal : 100-140 mg/dL

Impaired Glucose Tolerance : 141-199 mg/dL
Diabetes : >/=200 mg/dL
Method : Hexokinase
---------------------------------
- ADA Guidelines (2019) are adopted for the evaluation of Diabetic Status.


*33200664*
Helpline : 040-21000000

T3,T4 & TSH

Total T3 : 1.25 Adult : 0.6-1.81 ng/mL

Method : Chemiluminescence Immuno Assay (CLIA)
Total T4 : 9.30 Adult : 3.2-12.6 µg/dL

TSH : 1.61 Adult : 0.35-5.5 µIU/mL

---------------------------------
- Patient preparation is particularly important for hormone studies, results of which may be markedly affected by
many factors such as stress, position, fasting state, time of the day, preceding diet and drug therapy.
- The levels of T3 helps in the diagnosis of T3 Thyrotoxicosis and monitoring the course of hyperthyroidism.
- T3 is not recommended for diagnosis of hypothyroidism as decreased values have minimal clinical significance.
- Values below the lower limits can be caused by a number of conditions including non-thyroidal illness, acute and chronic
stress and hypothyroidism.
- Elevated level of T4 are seen in hyperthyroidism, pregnancy, euthyroid patients with increased serum Thyroxine Binding
Globulin.
- Decreased levels are noted in hypothyroidism, hypoproteinemia, euthyroid sick syndrome, decrease in Thyroxine Binding
Globulin.
- TSH levels are increased in primary hypothyroidism, insufficient thyroid hormone replacement therapy, Hashimotos
thyroiditis, use of amphetamines, dopamine antagonists, iodine containing agents, lithium and iodine induced or deficiency
goiter.
- Decreased levels of TSH may be seen in Graves Disease, Toxic multinodular Goitre, Thyroiditis, Excessive treatment
with thyroid hormone replacement and central Hypothyroidism.


*33200664*
Helpline : 040-21000000

LIPID PROFILE (LP)

Serum Status : Clear
Triglycerides : 165 Desirable Level : < 150 mg/dL

Borderline : 150 - 199 mg/dL
High : 200 - 499 mg/dL
Very High : > 499 mg/dL
Method : GPO-POD
Total Cholesterol : 242 Desirable Level : < 200 mg/dL

Borderline : 200 - 240 mg/dL
Undesirable : > 240 mg/dL
Method : CHOD-POD
LDL Cholesterol. : 167 Optimal : < 100 mg/dL

Near Optimal : 100 - 129 mg/dL
Borderline High : 130 - 159 mg/dL
High : 160 - 189 mg/dL
Very High : > 189 mg/dL
Method: Calculation
HDL Cholesterol : 42 Desirable Level : > 60 mg/dL

Optimal : 40 - 59 mg/dL
Undesirable : < 40 mg/dLL
Method : Enzymatic Immunoinhibition
VLDL : 33 < 30 mg/dL

Method: Calculation
Total Cholesterol/HDL Cholesterol Ratio : 5.76 Low Risk : 3.3 - 4.4

Average Risk : 4.5 - 7.1
Moderate Risk : 7.2 - 11.0
Method: Calculation
LDL Cholesterol/HDL Cholesterol Ratio : 3.98 Desirable Level : 0.5 - 3.0

Borderline Risk : 3.0 - 6.0
High Risk : > 6.0
Method: Calculation
---------------------------------
- Lipid profile is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, the
results of this tests can identify certain genetic diseases and can determine approximate risks for cardiovascular disease,
certain forms of pancreatitis and other diseases.


*33200664*
Helpline : 040-21000000

LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 0.6 0.3 - 1.2 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate
Conjugated Bilirubin : 0.1 Less than 0.2 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate
Unconjugated Bilirubin : 0.5 0.3 - 1.00 mg/dL

Method : Dichlorophenyl Diazonium Tetrafluroborate + Calculation
ALT/SGPT : 21 Male (Adult) : 0 - 50 U/L

Newborn/Infant : 13 - 45 U/L U/L
Method : IFCC, Kinetic
AST/SGOT : 18 Male (Adult) : 0 - 50 U/L

Newborn : 25 - 75 U/L
Infant : 15 - 60 U/L U/L
Alkaline Phosphatase : 99 30 - 120 U/L

Method : Kinetic PNPP- AMP
Total Protein (TP) : 7.2 6.6 - 8.3 g/dL

Method : Biuret
Albumin : 4.4 Adult : 3.5 - 5.2 g/dL

New Born (0-4 days) : 2.8 - 4.4 g/dL
Method : Bromocresol Green (BCG)
Globulin : 2.8 1.8 - 3.6 g/dL

Method : Biuret + Bromocresol Green + Calculation
Albumin / Globulin (A/G) Ratio : 1.6 0.8 - 2.0
Gamma-Glutamyl Transferase (GGT) : 67 0 - 55 U/L

---------------------------------
- Liver function test aid in the diagnosis of various pre hepatic, hepatic & post hepatic causes of dysfunction like hemolytic
anemias, viral & alcoholic hepatitis and cholestasis of obstructive causes.
- The test encompasses hepatic excretory, synthetic function and also hepatic parenchymal cell damage.
- LFT helps in evaluating severity, monitoring therapy and assessing prognosis of liver disease and dysfunction.


*33200664*

Sample Type : Whole Blood - EDTA Ref no. :
GLYCOSYLATED HAEMOGLOBIN (HbA1c)
Glycosylated Haemoglobin : 7.9 Non Diabetic : < 5.6%

Prediabetic Range : 5.7 - 6.4%
Diabetic Range : > 6.5%
Method : High Performance Liquid Chromatography (HPLC)
---------------------------------
- Glycosylated hemoglobin is proportional to mean plasma glucose level during previous 6-12 weeks.
- Values may not be comparable with different methodologies and even different laboratories using the same methodology.
- Perform A1c at least twice annually in Diabetes patients to ascertain meeting of goals
- Perform A1c test quarterly in Diabetes patients whose therapy has changed and who are not meeting goals
- Recommended goal of A1c is < 7%
- ADA Guidelines 2019.
Released Date : 04/01/2020 14:48 Page 1 of 2

*33200664*

Sample Type : Whole Blood - EDTA Ref no. :
DR.SWETHA ANNARAM
CONSULTANT PATHOLOGIST
This is only a test report of your given sample to be correlated clinically by referring medical practitioner.
Released Date : 04/01/2020 14:48 Page 2 of 2

*33200664*
Bio-Rad CDM System PATIENT REPORT
VII Inst. #1. SN 15428 V2TURBO_A1c_2.0
Patient Data Analysis Data

Sample ID: 33200664 Analysis Performed: 01/04/2020 14:29:36
Patient ID: Injection Number: 3675
Name: Run Number: 148
Physician: Rack ID:
Sex: Tube Number: 4
DOB: Report Generated: 01/04/2020 14:41:22
Operator ID:
Comments:
NGSP Retention Peak

Peak Name % Area % Time (min) Area
A1a --- 1.1 0.177 23978
A1b --- 1.4 0.246 32405
F --- 1.2 0.281 26834
LA1c --- 2.1 0.412 48007
A1c 7.9* --- 0.515 151221
P3 --- 4.0 0.794 91012
P4 --- 1.5 0.869 34788
Ao --- 82.0 0.992 1858793
*Values outside of expected ranges Total Area: 2,267,039
HbA1c (NGSP) = 7.9* %
20.0
17.5
15.0
12.5
0.52
%A1c
10.0
A1c -
0.79
7.5
0.25
0.41
0.87
-
0.28
5.0
0.18
-
-
-
2.5
0.99
-
0.0
-
0.00 0.25 0.50 0.75 1.00 1.25 1.50

Time (min.)

Unlq6073 PDF

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Unlq6073 PDF

Uploaded by

Copyright:

Available Formats

Vijaya Diagnostic Centre

16-11-741/C/C, Beside TITAN Showroom, Dilsukhnagar, Hyderabad.

LABORATORY TEST REPORT

Creatinine : 0.8 Adult Male : 0.7 - 1.2 mg/dL

DR.SYED SHABBAR MASIH

Released Date 04/01/2020 15:53 Page 1 of 5

LABORATORY TEST REPORT

FASTING PLASMA GLUCOSE (FPG)

Fasting Plasma Glucose : 136 Normal : 70-100 mg/dL

2 hrs Post Lunch Plasma Glucose : 170 Normal : 100-140 mg/dL

DR.SYED SHABBAR MASIH

Released Date 04/01/2020 17:34 Page 2 of 5

LABORATORY TEST REPORT

T3,T4 & TSH

Total T3 : 1.25 Adult : 0.6-1.81 ng/mL

Total T4 : 9.30 Adult : 3.2-12.6 µg/dL

TSH : 1.61 Adult : 0.35-5.5 µIU/mL

DR.SYED SHABBAR MASIH

Released Date 04/01/2020 15:24 Page 3 of 5

LABORATORY TEST REPORT

LIPID PROFILE (LP)

Serum Status : Clear

Triglycerides : 165 Desirable Level : < 150 mg/dL

Total Cholesterol : 242 Desirable Level : < 200 mg/dL

LDL Cholesterol. : 167 Optimal : < 100 mg/dL

HDL Cholesterol : 42 Desirable Level : > 60 mg/dL

VLDL : 33 < 30 mg/dL

Total Cholesterol/HDL Cholesterol Ratio : 5.76 Low Risk : 3.3 - 4.4

LDL Cholesterol/HDL Cholesterol Ratio : 3.98 Desirable Level : 0.5 - 3.0

DR.SYED SHABBAR MASIH

Released Date 04/01/2020 15:53 Page 4 of 5

LABORATORY TEST REPORT

LIVER FUNCTION TEST - A (LFT-A)

Total Bilirubin : 0.6 0.3 - 1.2 mg/dL

Conjugated Bilirubin : 0.1 Less than 0.2 mg/dL

Unconjugated Bilirubin : 0.5 0.3 - 1.00 mg/dL

ALT/SGPT : 21 Male (Adult) : 0 - 50 U/L

AST/SGOT : 18 Male (Adult) : 0 - 50 U/L

Alkaline Phosphatase : 99 30 - 120 U/L

Total Protein (TP) : 7.2 6.6 - 8.3 g/dL

Albumin : 4.4 Adult : 3.5 - 5.2 g/dL

Globulin : 2.8 1.8 - 3.6 g/dL

Albumin / Globulin (A/G) Ratio : 1.6 0.8 - 2.0

Gamma-Glutamyl Transferase (GGT) : 67 0 - 55 U/L

DR.SYED SHABBAR MASIH

Released Date 04/01/2020 15:53 Page 5 of 5

LABORATORY TEST REPORT

Regn Date : 04/01/2020 10:30 Sample Collection : 04/01/2020 10:33

GLYCOSYLATED HAEMOGLOBIN (HbA1c)

TEST NAME RESULT BIOLOGICAL REFERENCE INTERVAL

Glycosylated Haemoglobin : 7.9 Non Diabetic : < 5.6%

Released Date : 04/01/2020 14:48 Page 1 of 2

LABORATORY TEST REPORT

Regn Date : 04/01/2020 10:30 Sample Collection : 04/01/2020 10:33

Released Date : 04/01/2020 14:48 Page 2 of 2

Patient Data Analysis Data

NGSP Retention Peak

*Values outside of expected ranges Total Area: 2,267,039

HbA1c (NGSP) = 7.9* %

0.00 0.25 0.50 0.75 1.00 1.25 1.50

You might also like